South America Covid Hotspot Has Few Shots to Slow Record Deaths
(Bloomberg) --
Containing the pandemic is tough even for countries that boast enviable vaccination rates such as Chile and Uruguay. So spare a thought for Paraguay, that which now has one of the world's worst outbreaks by one measure with a meager stock of vaccines and few on the way.
The landlocked country in the heart of South America managed against all odds to contain the virus during the early months of the pandemic in 2020 after it closed its borders and ordered an early lockdown. But now the sick are dying for lack of intensive care beds as the highly contagious P1 variant that began in neighboring Brazil spreads alongside public fatigue with prevention measures and vaccine shortages.
Paraguay, where Covid-19 has killed more than 8,800 people, now has the highest per capita death rate over the past 7 days with nearly 109 fatalities per 1 million people, according to data compiled by Bloomberg. Uruguay, which like Paraguay shares a border with Brazil, held the position for weeks and stands in second at the moment.
Deaths and infections will probably continue to rise the next two months until the vaccination program and mobility restrictions start to bring them down, said Guillermo Sequera, who leads Paraguay's equivalent to the Centers for Disease Control.
“What's important isn't so much being in the oven at the moment,” he said in a telephone interview from Asuncion. “It's about staying in the oven for as little time as possible.”
Public anger over shortages of vaccines and Covid-19 medicine boiled over in March with days of street protests demanding the ouster of President Mario Abdo Benitez. The president narrowly avoided the start of impeachment proceedings thanks to the last minute backing of a rival faction of the ruling Colorado Party.
The arrival of more vaccines and the political establishment's historic ability to diffuse social tensions through clientelism mean Paraguay is unlikely to suffer the violent protests that have exploded in other South American nations recently, said Luis Ortiz, a sociologist at the Social Sciences Institute of Paraguay.
“Political stability will continue and there won't be big social convulsions,” he said.
The Abdo Benitez administration has obtained about 707,000 of the 8.9 million shots purchased or pledged as donations. That means Paraguay only has enough shots on hand to fully vaccinate 5% of its 7 million people.
So far Paraguay has administered just 304,725 shots, meaning that 3.5% of the population has received a first dose with just 0.7% considered fully inoculated, according to the Bloomberg vaccine tracker.
Chile and Uruguay have fully covered 41% and 28% of the population with vaccines respectively and are still seeing a jump in cases.
Contracts to buy millions of shots through the World Health Organization's Covax facility as well as deals with pharmaceutical companies in Russia and India have yet to yield meaningful deliveries.
India's own Covid-19 crisis will probably delay shipments of the 2 million shots it bought from Bharat Biotech. Paraguay's lack of diplomatic relations with China -- it's one of just 15 countries that still recognize Taiwan -- means it can't easily buy shots from vaccine makers there who have been busy supplying millions of doses to other developing countries.
One of Taiwan's Allies Weighs Embracing China for Vaccines
Vaccine corruption has also come to light with the Health Ministry detecting about 500 cases of people who might have received shots out of turn. The scandal led Colorado Party Senator Mirta Gusinky to resign earlier this month.
Meanwhile, thousands of desperate Paraguayans with the money for airfare and hotels have joined the flood of Latin Americans flying to the U.S. to seek vaccines.
The government thinks about half of the 6,000 to 7,000 Paraguayans who flew to the U.S. this year got vaccinated, said Sequera, citing a recent survey of returning travelers.
Paraguay can still slash fatalities if it can immunize the 30% of the population over 50 and young people with preexisting health conditions that today account for about 90% of deaths, he said. The spread of the P1 variant puts herd immunity increasingly out of reach.
“It's important to vaccinate vulnerable groups,” Sequera said. “The virus is going to continue circulating, but with a diminishing mortality.”
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.